Nifuroxazide-loaded cubosomes exhibit an advancement in pulmonary delivery and attenuate bleomycin-induced lung fibrosis by regulating the STAT3 and NF-κB signaling: A new challenge for unmet therapeutic needs-Reference-Cited by-同舟云学术

Nifuroxazide-loaded cubosomes exhibit an advancement in pulmonary delivery and attenuate bleomycin-induced lung fibrosis by regulating the STAT3 and NF-κB signaling: A new challenge for unmet therapeutic needs

Published:2022-04 Issue: Volume:148 Page:112731
ISSN:0753-3322
Container-title:Biomedicine & Pharmacotherapy
language:en
Short-container-title:Biomedicine & Pharmacotherapy

Author:

Saber Sameh,Nasr Mohamed,Kaddah Mohamed M.Y.,Mostafa-Hedeab Gomaa,Cavalu Simona,Mourad Ahmed A.E.,Gaafar Ahmed Gaafar Ahmed,Zaghlool Sameh S.,Saleh Safaa,Hafez Mohamed M.,Girgis Samuel,Elgharabawy Rehab Mohamed,Nader Karim,Alsharidah Mansour,Batiha Gaber El-Saber,El-Ahwany Eman,Amin Noha A.,Elagamy Heba I.,Shata Ahmed,Nader Reem,Khodir Ahmed E.

Publisher

Elsevier BV

Subject

Pharmacology,General Medicine

Reference52 articles.

1. Idiopathic pulmonary fibrosis: treatment and prognosis;Fujimoto;Clin. Med. Insights Circ. Respir. Pulm. Med.,2015

2. Estimated research and development investment needed to bring a new medicine to market, 2009-2018;Wouters;JAMA,2020

3. Blockade of IL-6 Trans signaling attenuates pulmonary fibrosis;Le;J. Immunol.,2014

4. Genetic partitioning of interleukin-6 signalling in mice dissociates Stat3 from Smad3-mediated lung fibrosis;O’Donoghue;EMBO Mol. Med.,2012

5. STAT-3 contributes to pulmonary fibrosis through epithelial injury and fibroblast-myofibroblast differentiation;Pedroza;FASEB J.,2016

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unlocking the potential of nanocarrier-mediated mRNA delivery across diverse biomedical frontiers: A comprehensive review;International Journal of Biological Macromolecules;2024-05

2. Revolutionizing the Treatment of Idiopathic Pulmonary Fibrosis: From Conventional Therapies to Advanced Drug Delivery Systems;AAPS PharmSciTech;2024-04-08

3. A Synoptic Update on Smart Lipid Nanocarrier: Cubosomes, and their Design Development, and Recent Challenges;Current Pharmaceutical Biotechnology;2024-03

4. Mechanisms underlying dose-limiting toxicities of conventional chemotherapeutic agents;Journal of Chemotherapy;2024-01-05

5. Unveiling the capability of novel cobalt/barium stannate nanoparticles embedded functionalized MWCNTs nanocomposite for electrochemical investigation of antibiotic drug nifuroxazide;Materials Today Chemistry;2024-01